Acurx Pharmaceuticals Inc — Balance Sheet (NASDAQ:ACXP) | MetaTrader

Open full chart

Financials

Overview 明細書 Statistics

Quarterly Annual

Total assets 13.25 M9.38 M7.71 M3.86 M7.69 M Total liabilities 843.91 K2.06 M3.04 M3.24 M2.42 M Total equity 12.41 M7.32 M4.67 M615.12 K5.27 M Total liabilities & shareholders' equities 13.25 M9.38 M7.71 M3.86 M7.69 M Total debt ————— Net debt —————

ニュース

Acurx Pharmaceuticals, Inc. (ACXP) Q4 2025 Earnings Call Transcript

Acurx Pharmaceuticals、2025年第4四半期で現金増強と研究開発の進展を報告

Earnings call transcript: Acurx Pharmaceuticals Q4 2025 reveals cash boost and R&D progress

Acurx Pharmaceuticals、新たなrCDI治験開始で株価3%超上昇

Acurx Pharmaceuticals stock gains over 3% on new rCDI trial launch

What's Going On With Acurx Pharmaceuticals Stock Today? - Acurx Pharmaceuticals (NASDAQ:ACXP)

Why Is Acurx Pharmaceuticals Stock Falling Thursday? - Acurx Pharmaceuticals (NASDAQ:ACXP)

U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.61%

Why Is Acurx Pharmaceuticals Stock Up Over 105% Today? - Acurx Pharmaceuticals (NASDAQ:ACXP)

Has Acurx Pharmaceuticals (ACXP) Outpaced Other Medical Stocks This Year?

Acurx Pharmaceuticals, Inc. (ACXP) Q3 2025 Earnings Call Transcript

アキュラックスのイベザポルスタット、臨床試験で腸内細菌叢を保護する特性を示す